Exhibit 10.2

RELEASE

You Are Advised to Consult with an Attorney Before Signing this Release of
Claims

1. Release. In consideration of the benefits to be provided under that certain
Separation Agreement between Diana F. Hausman, M.D. (“Executive”) and
Oncothyreon Inc. (the “Company”), the sufficiency of which Executive
acknowledges, Executive, for herself and her heirs, executors, administrators
and assigns, does hereby release, acquit and forever discharge the Company, and
each of its subsidiaries and affiliates, their present and former officers,
directors, managers, executives, shareholders, members, agents, attorneys,
employees and employee benefit plans (and the fiduciaries thereof), and the
successors, predecessors and assigns of each of the foregoing (individually, a
“Company Released Party” and collectively, the “Company Released Parties”) of
and from any and all claims, actions, causes of action, complaints, charges,
demands, rights, damages, debts, sums of money, accounts, financial obligations,
suits, expenses, attorneys’ fees and liabilities of whatever kind or nature, in
law, at equity or otherwise, whether accrued, absolute, contingent, unliquidated
or otherwise, and whether now known or unknown, suspected or unsuspected
(“Claims”) that Executive, individually or as a member of a class, now has, owns
or holds, or has at any time had, owned or held, arising on or prior to the date
hereof, against any Company Released Party that arises out of, or is related to
the Separation Agreement or the Executive’s employment with the Company or
affiliate or subsidiary, or any termination of such employment, including Claims
(i) for unpaid wages, salary or incentive payments, (ii) for breach of contract,
wrongful discharge, impairment of economic opportunity, defamation, intentional
infliction of emotional harm or other tort, (iii) any violation of applicable
state and local labor and employment laws (including, without limitation, all
laws concerning unlawful and unfair labor and employment practices), and
(iv) for employment discrimination under any applicable federal, state or local
statute, provision, order or regulation, and including, without limitation, any
claims under Title VII of the Civil Rights Act of 1964, the Civil Rights Act of
1988, the Fair Labor Standards Act, the Americans with Disabilities Act, the
Employee Retirement Income Security Act of 1974 (“ERISA”), the Age
Discrimination in Employment Act (“ADEA”), the Washington laws against
discrimination, and any similar or analogous state statute, excepting only:

(a) rights of Executive arising under, or preserved by, this Release;

(b) rights of Executive to benefits pursuant to the Separation Agreement;

(c) the right of Executive to receive COBRA continuation coverage in accordance
with applicable law;

 

1

--------------------------------------------------------------------------------

(d) claims for benefits under any health, disability, retirement, life insurance
or other, similar employee benefit plan (within the meaning of Section 3(3) of
ERISA) of the Company;

(e) rights to indemnification the Executive has or may have under that certain
Indemnification Agreement effective as of December 17, 2012 between the Company
and Executive or the bylaws or certificate of incorporation of the Company or as
an insured under any director’s and officer’s liability insurance policy now or
previously in force.

2. Unknown Claims. Executive hereby acknowledges that she is aware of the
principle that a general release does not extend to claims that the releasor
does not know or suspect to exist at the time of executing the release, which,
if known, must have materially affected the releasor’s settlement with the
releasee. With knowledge of this principal, Executive hereby agrees to expressly
waive any right she may have to that effect.

3. No Admission. Executive acknowledges and agrees that the release of claims
set forth in this Release is not to be construed in any way as an admission of
liability whatsoever by any Company Released Party and any such liability is
expressly denied.

4. Non-disparagement. From and after the date hereof, (a) Executive shall not
make any statement, regardless of whether such statement is truthful, nor take
any action that criticizes, ridicules or disparages or is otherwise derogatory
of any of the members of the Board of the Company and/or its senior executive
officers or which could reasonably be expected to harm the reputation or good
will of the Company, the members of the Board of the senior executive officers,
and (b) the Company shall not make, and shall use its reasonable best efforts to
ensure that its senior executive officers and members of the Board shall not
make, directly or indirectly, any statement, regardless of whether such
statement is truthful, nor take any action that criticizes, ridicules or
disparages or is otherwise derogatory of Executive or which could reasonably be
expected to harm the reputation or goodwill of Executive.

5. No Filings. Executive represents that she has not filed any claim, complaint,
charge or lawsuit against any Company Released Party with any governmental
agency or state or federal court and that neither she nor any person or entity
acting on her behalf will commence any proceeding of any kind or nature, whether
administrative or judicial, or otherwise participate in any proceeding or seek
any form of damages or equitable relief against any Company Released Parties
with respect to Claims that are the subject of this Release. Notwithstanding the
foregoing, nothing in this Release prohibits Executive from filing a charge with
the Equal Employment Opportunity Commission (“EEOC”) or participating in any
investigation or proceeding conducted by the EEOC; provided, however, that
Executive waives any right to recover damages, costs or attorneys’ fees or other
relief in any charge, proceeding or action brought against a Company Released
Party

 

2

--------------------------------------------------------------------------------

by Executive or by any other person or entity on Executive’s behalf, including,
without limitation, the EEOC, asserting any Claims released by Executive herein.
Further notwithstanding the foregoing, nothing in this Release shall be deemed
to preclude Executive from (i) challenging the knowing and voluntary nature of
her waiver of ADEA claims or any breach of this Release or seeking its
enforcement in a court of competent jurisdiction, or (ii) pursuing any rights
she may have to unemployment insurance benefits or workers’ compensation
benefits.

6. Adequate Time for Consideration. Executive acknowledges that she has been
given a period of twenty-one (21) calendar days to consider whether to execute
this Release prior to entering into it. Any modifications to this Release,
whether material or not, shall not extend or re-start the twenty-one
(21) calendar day period. Executive agrees to notify the Company of acceptance
of this Release by delivering a signed copy of this Release to the Company.
Executive understands that the entire twenty-one (21) calendar day period may be
taken to consider this Release. Executive may return this Release in less than
the twenty-one (21) calendar day period. By signing and returning this Release,
Executive acknowledges that the consideration period afforded her was a
reasonable period of time to consider fully each and every term of this Release
and to seek advice of counsel with respect to this Release. If Executive accepts
the terms hereof and executes this Release, she may thereafter, for a period of
seven (7) calendar days following (and not including) the date of execution,
revoke this Release. If Executive elects to revoke this Release, written notice
of such revocation must be actually delivered to the Chief Financial Officer of
the Company within the seven (7) calendar day period. If no such revocation
occurs, this Release becomes irrevocable in its entirety, and binding and
enforceable against Executive, on the day next following the day on which such
seven (7) calendar day period elapses. If such revocation occurs, Executive
shall irrevocably forfeit any right to the benefits under Section 2(b) and
(c) of the Separation Agreement.

7. Advice of Counsel. Executive acknowledges that, by this writing, she has been
advised by the Company to seek the advice and assistance of an attorney with
regard to this Release prior to signing it.

8. Separation Agreement Benefits. Executive acknowledges that the benefits
provided in Section 2(b) and (c) of the Separation Agreement are in addition to
anything of value which Executive is entitled to from the Company.

9. Counterparts. This Release may be executed in counterparts, and each
counterpart will have the same force and effect as an original and will
constitute an effective, binding agreement on the part of the undersigned.

10. Incorporation. This Release is hereby incorporated into and forms part of
the Separation Agreement.

 

3

--------------------------------------------------------------------------------

IN WITNESS WHEREOF, each of the parties has executed this Release, in the case
of the Company by a duly authorized officer, as of the date written below.

 

ONCOTHYREON INC.

By  

/s/ Christopher Henney

Name  

Christopher Henney, Ph.D., D. Sc.

Title  

Interim Chief Executive Officer

Date  

March 31, 2016

 

DIANA F. HAUSMAN, M.D.

/s/ Diana F. Hausman

Date   March 31, 2016

 

4